[{"address1": "601 Brickell Key Drive", "address2": "Suite 1000", "city": "Miami", "state": "FL", "zip": "33131", "country": "United States", "phone": "305 203 2034", "website": "https://www.smmttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.", "fullTimeEmployees": 159, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert W. Duggan", "age": 81, "title": "Co-CEO & Executive Chairman", "yearBorn": 1944, "fiscalYear": 2024, "totalPay": 158613, "exercisedValue": 0, "unexercisedValue": 1133457}, {"maxAge": 1, "name": "Dr. Mahkam  Zanganeh D.D.S., M.B.A.", "age": 55, "title": "Co-CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1161021, "exercisedValue": 0, "unexercisedValue": 128563160}, {"maxAge": 1, "name": "Mr. Manmeet Singh Soni CPA", "age": 47, "title": "COO, CFO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 1261021, "exercisedValue": 0, "unexercisedValue": 107858016}, {"maxAge": 1, "name": "Prof. Dame Kay Davies DBE, FRS CBE", "age": 74, "title": "Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bhaskar  Anand", "age": 48, "title": "Chief Accounting Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nathan  LiaBraaten", "title": "Senior Director of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dave  Gancarz", "title": "Chief Business & Strategy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Fong  Clow", "title": "Chief Biometrics Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Urte  Gayko Ph.D.", "age": 54, "title": "Chief Regulatory, Quality & Pharmacovigilance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Allen S. Yang M.D., Ph.D.", "age": 57, "title": "Head of R&D Strategy", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 10, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 18.83, "open": 18.98, "dayLow": 18.98, "dayHigh": 20.18, "regularMarketPreviousClose": 18.83, "regularMarketOpen": 18.98, "regularMarketDayLow": 18.98, "regularMarketDayHigh": 20.18, "payoutRatio": 0.0, "beta": -1.512, "forwardPE": -19.629953, "volume": 2801719, "regularMarketVolume": 2801719, "averageVolume": 2825740, "averageVolume10days": 2112190, "averageDailyVolume10Day": 2112190, "bid": 16.38, "ask": 18.68, "bidSize": 2, "askSize": 2, "marketCap": 14650630144, "fiftyTwoWeekLow": 15.55, "fiftyTwoWeekHigh": 36.91, "allTimeHigh": 36.91, "allTimeLow": 0.66, "fiftyDayAverage": 17.9133, "twoHundredDayAverage": 21.80555, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 14417503232, "profitMargins": 0.0, "floatShares": 124783458, "sharesOutstanding": 744442538, "sharesShort": 35753740, "sharesShortPriorMonth": 31236590, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.048, "heldPercentInsiders": 0.86053, "heldPercentInstitutions": 0.14397, "shortRatio": 14.04, "shortPercentOfFloat": 0.3019, "impliedSharesOutstanding": 744442538, "bookValue": 0.258, "priceToBook": 76.279076, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -921617024, "trailingEps": -1.25, "forwardEps": -1.0025495, "enterpriseToEbitda": -15.42, "52WeekChange": 0.08280611, "SandP52WeekChange": 0.19362879, "quoteType": "EQUITY", "currentPrice": 19.68, "targetHighPrice": 42.77745, "targetLowPrice": 12.156036, "targetMeanPrice": 32.671886, "targetMedianPrice": 35.647427, "recommendationMean": 1.625, "recommendationKey": "buy", "numberOfAnalystOpinions": 13, "totalCash": 238554000, "totalCashPerShare": 0.32, "ebitda": -934987008, "totalDebt": 5428000, "quickRatio": 3.674, "currentRatio": 3.796, "debtToEquity": 2.823, "returnOnAssets": -1.5288, "returnOnEquity": -2.92492, "freeCashflow": 73795752, "operatingCashflow": -269664992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SMMT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Summit Therapeutics Inc.", "longName": "Summit Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1768005232, "regularMarketTime": 1767992400, "regularMarketChangePercent": 4.51408, "regularMarketPrice": 19.68, "exchange": "NGM", "messageBoardId": "finmb_11611587", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": -0.91463566, "postMarketPrice": 19.5, "postMarketChange": -0.1800003, "regularMarketChange": 0.85, "regularMarketDayRange": "18.98 - 20.18", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2825740, "fiftyTwoWeekLowChange": 4.13, "fiftyTwoWeekLowChangePercent": 0.26559487, "fiftyTwoWeekRange": "15.55 - 36.91", "fiftyTwoWeekHighChange": -17.23, "fiftyTwoWeekHighChangePercent": -0.46681115, "fiftyTwoWeekChangePercent": 8.280611, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1425565800000, "twoHundredDayAverageChange": -2.1255493, "twoHundredDayAverageChangePercent": -0.09747745, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Summit Therapeutics plc", "nameChangeDate": "2026-01-09", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "earningsTimestamp": 1760963400, "earningsTimestampStart": 1760963400, "earningsTimestampEnd": 1760963400, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.25, "epsForward": -1.0025495, "epsCurrentYear": -0.76667, "priceEpsCurrentYear": -25.669455, "fiftyDayAverageChange": 1.7667007, "fiftyDayAverageChangePercent": 0.098625086, "displayName": "Summit Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]